Jason S. Lewis, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Email: mibeditor@wmis.org
Research Interests
The Lewis lab research interests are focused on the development of radiopharmaceuticals for targeted diagnosis and treatment of cancer. By combining small- and biomolecule-based targeting agents with positron-emitting or therapeutic radioisotopes, we can interrogate molecular profiles of cancer using noninvasive nuclear imaging or treat tumors specifically with endoradiotherapy. Our research program is a molecular-imaging-based program focused on the targeting of nonstandard nuclides, with an emphasis on developing these novel radiopharmaceuticals for clinical translation
Published Articles in MIB:
Lewis, J.S. Changing of the Guard at Molecular Imaging & Biology. Mol Imaging Biol 22, 1–3 (2020). https://doi.org/10.1007/s11307-019-01446-y
Carter, L.M., Kesner, A.L., Pratt, E.C. et al. The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides. Mol Imaging Biol 22, 73–84 (2020). https://doi.org/10.1007/s11307-019-01337-2
Escorcia, F.E., Steckler, J.M., Abdel-Atti, D. et al. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Mol Imaging Biol 20, 808–815 (2018). https://doi.org/10.1007/s11307-018-1177-z